• ImmunoGen Announces Sale of Residual Kadcyla Royalties firstwordpharma
    January 09, 2019
    MTS Health Partners, L.P. acted as exclusive financial advisor to ImmunoGen and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. acted as special transactional counsel to ImmunoGen.
PharmaSources Customer Service